N-acetyl glucoside or galactoside compound of epothilone B and enzyme method preparation and application of N-acetyl glucoside or galactoside compound

Li Yuezhong,Zhang Peng,Wu Changsheng,Tang Yajie
2020-01-01
Abstract:The invention discloses a N-acetyl glucoside or galactoside compound of epothilone B, which is epothilone-B-7-O-beta-D N-acetyl glucoside or epothilone-B-7-O-beta-D galactoside. The compound is obtained by performing mediated glycosylation reaction on epothilone-B and UDP-O-alpha-N-acetyl-Dglucose or UDP-O-alpha-D-galactose and Q318C or M296A mutation protein of glycosyltransferase BsGT-1. The invention further discloses an application of two compounds to preparation of medicines for preventing and treating liver cancer. When the concentration of the compound namely the epothilone-B-7-O-beta-Dgalactoside is 1.09 M, the epothilone-B-7-O-beta-D galactoside has semi-inhibition effects on human hepatoma carcinoma cells HepG2; and compared with the toxicity of epothilone-B prodrugs, the toxicity of the epothilone-B-7-O-beta-D galactoside on normal liver cells HL7702 is reduced by 3116 times. The glucoside is hopeful to increment of application value of epothilone on antineoplastic activity, and the social benefits and the economic value are increased.
What problem does this paper attempt to address?